T

TiumBio Co Ltd
KOSDAQ:321550

Watchlist Manager
TiumBio Co Ltd
KOSDAQ:321550
Watchlist
Price: 6 030 KRW -2.43% Market Closed
Market Cap: 166.9B KRW

TiumBio Co Ltd
Investor Relations

TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Huntaek Kim
Chief Executive Officer
No Bio Available
Ms. Hyunsil Koh
Chief Financial Officer
No Bio Available

Contacts

Address
GYEONGGI-DO
Seongnam
4F, Dasan Tower, 49, Daewangpangyo-ro 644beon-gil, Bundang-gu
Contacts
+82316001500
www.tiumbio.com